- Home
- HQL
as of 12-04-2025 4:00pm EST
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 510.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 120.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.34 - $14.37 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered HQL Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
10% Owner
Avg Cost/Share
$14.14
Shares
41,623
Total Value
$588,549.22
Owned After
2,837,633
SEC Form 4
10% Owner
Avg Cost/Share
$14.10
Shares
6,989
Total Value
$98,544.90
Owned After
2,837,633
SEC Form 4
10% Owner
Avg Cost/Share
$14.07
Shares
40,208
Total Value
$565,726.56
Owned After
2,837,633
SEC Form 4
10% Owner
Avg Cost/Share
$13.99
Shares
24,328
Total Value
$340,348.72
Owned After
2,837,633
SEC Form 4
10% Owner
Avg Cost/Share
$13.99
Shares
2,026
Total Value
$28,343.74
Owned After
2,837,633
SEC Form 4
10% Owner
Avg Cost/Share
$14.13
Shares
700
Total Value
$9,891.00
Owned After
2,837,633
SEC Form 4
10% Owner
Avg Cost/Share
$14.28
Shares
15,116
Total Value
$215,856.48
Owned After
2,837,633
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | HQL | 10% Owner | Sep 22, 2025 | Sell | $14.14 | 41,623 | $588,549.22 | 2,837,633 | |
| Saba Capital Management, L.P. | HQL | 10% Owner | Sep 19, 2025 | Sell | $14.10 | 6,989 | $98,544.90 | 2,837,633 | |
| Saba Capital Management, L.P. | HQL | 10% Owner | Sep 18, 2025 | Sell | $14.07 | 40,208 | $565,726.56 | 2,837,633 | |
| Saba Capital Management, L.P. | HQL | 10% Owner | Sep 17, 2025 | Sell | $13.99 | 24,328 | $340,348.72 | 2,837,633 | |
| Saba Capital Management, L.P. | HQL | 10% Owner | Sep 16, 2025 | Sell | $13.99 | 2,026 | $28,343.74 | 2,837,633 | |
| Saba Capital Management, L.P. | HQL | 10% Owner | Sep 15, 2025 | Sell | $14.13 | 700 | $9,891.00 | 2,837,633 | |
| Saba Capital Management, L.P. | HQL | 10% Owner | Sep 11, 2025 | Sell | $14.28 | 15,116 | $215,856.48 | 2,837,633 |
Compare HQL vs Leading Stocks
See how HQL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HQL abrdn Life Sciences Investors Shares of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.